{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:47:52Z","timestamp":1792626472710,"version":"4.5.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Thyroid\u00ae"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Autoimmune diseases tend to cluster in the same individual or in families. Four types of autoimmune polyglandular syndromes (APS) have been described based on the combination of endocrine and\/or non-endocrine autoimmune diseases. In particular, type-3 APS is defined by the association of an autoimmune thyroid disease (ATD) and other autoimmune diseases and has a multifactorial etiology. The natural history of autoimmune diseases is characterized by three stages: potential, subclinical, and clinical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>To determine the prevalence of organ-specific autoantibodies (anti-adrenal, anti-ovary [StCA], anti-pituitary [APA], anti-parietal cells [PCA], anti-tissue transglutaminase [tTGAb], anti-mitochondrial [AMA], anti-glutamic acid decarboxylase [GADA], anti-nicotinic acetylcholine receptor) in patients with ATD and to define the stage of the disease in patients with positive autoantibodies. From January 2016 to November 2018, 1502 patients (1302 female; age 52.7\u2009\u00b1\u200914.7 [mean\u2009\u00b1\u2009standard deviation] years, range 18\u201386 years) with ATD (1285\/1502 [85.6%] with chronic autoimmune thyroiditis and 217\/1502 [14.4%] with Graves' disease) were prospectively enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The most common organ-specific autoantibodies were PCA (6.99%) and GADA (2.83%), while the prevalence of the remaining autoantibodies was \u22641%. All autoimmune diseases, but celiac disease, were predominant at the potential stage. Sex, ATD type, smoking habit, and coexistence of other autoimmune diseases correlated with the susceptibility to develop chronic atrophic gastritis (CAG) or autoimmune diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The association between ATD and CAG was the most common manifestation of type-3 APS, mainly at the potential stage, that could lead to appropriate follow-up for early detection and timely treatment of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/thy.2021.0170","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T01:20:14Z","timestamp":1626744014000},"page":"1416-1423","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Screening of Organ-Specific Autoantibodies in a Large Cohort of Patients with Autoimmune Thyroid Diseases"],"prefix":"10.1177","volume":"31","author":[{"given":"Tania","family":"Pilli","sequence":"first","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Dalmazio","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunetta","family":"Porcelli","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cantara","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tabucchi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pini","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Spreafico","sequence":"additional","affiliation":[{"name":"Department of Innovation, Experimentation, Clinical and Translational Research, Azienda Ospedaliera Universitaria Senese, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cartocci","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."},{"name":"Department of Medical Biotechnologies, University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Forleo","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Pacini","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Scapellato","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Castagna","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical and Neurological Sciences and University of Siena, Siena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-19800401-07"},{"key":"e_1_3_7_3_2","first-page":"9","article-title":"Update on autoimmune polyendocrine syndromes (APS)","volume":"74","author":"Betterle C","year":"2003","unstructured":"Betterle C, , Zanchetta R. 2003. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed, 74:9\u201333.","journal-title":"Acta Biomed"},{"key":"e_1_3_7_4_2","first-page":"e181","author":"Boelaert K","unstructured":"Boelaert K, , Newby PR, , Simmonds MJ, , Holder RL, et al. 2010 Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123:183 e181\u2013e189.","journal-title":"et al"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-013-0055-6"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2003.06.005"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871530314666140626113111"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.03.025"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102368"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.479"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.11.048"},{"key":"e_1_3_7_12_2","first-page":"100","article-title":"Thyroid dysfunction is prevalent in autoimmune hepatitis: a case control study","volume":"22","author":"Khoury T","year":"2020","unstructured":"Khoury T, , Kadah A, , Mari A, et al. 2020. Thyroid dysfunction is prevalent in autoimmune hepatitis: a case control study. Isr Med Assoc J, 22:100\u2013103.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7502935"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2004.11.004"},{"key":"e_1_3_7_15_2","author":"T\u00f6rn C","unstructured":"T\u00f6rn C, , Mueller PW, , Schlosser M, et al.; Participating Laboratories 2008. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846\u2013852.","journal-title":"Diabetologia"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002497"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3026-2"},{"key":"e_1_3_7_18_2","volume-title":"et al","author":"Conrad K","unstructured":"Conrad K, , Schossler W, , Falk H, et al. Autoantigens, autoantibodies, autoimmunity. In: Autoantibodies in Organ Specific Autoimmune Diseases. A Diagnostic Reference. Second edition. PABST Science Publ, Lengerich, Germany, 2017, Vol 8."},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04056.x"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqy061"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0737"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.10.001"},{"key":"e_1_3_7_23_2","first-page":"3507","article-title":"Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease","volume":"83","author":"Laureti S","year":"1998","unstructured":"Laureti S, , De Bellis A, , Muccitelli VI, et al. 1998. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab, 83:3507\u20133511.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1997.262-ce1153.x"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000280"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.07.025"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01852-w"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-924153"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1995.0047"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0755-2"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0041"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.08.006"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0445-5"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2748"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916930701620209"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048840"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1285-6"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0551"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041327-199509000-00008"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13005"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2004.11.008"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0860"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1544"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.15.1726"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02986.x"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.11.1304"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.8.977"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.023937"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1172"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1591-y"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.08.011"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.38.121"}],"container-title":["Thyroid\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/thy.2021.0170","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2021.0170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2021.0170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:08:23Z","timestamp":1777586903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/thy.2021.0170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1089\/thy.2021.0170"],"URL":"https:\/\/doi.org\/10.1089\/thy.2021.0170","relation":{},"ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}